In addition, treatment with the SCD1 inhibitors MF-438, CAY10566, and A939572 increased the sensitivity of ovarian cancer cells to the ferroptosis inducers RSL3 and erastin (Wang et al., 2022a). Here, SCD is linked to ovarian carcinoma.